Neubase therapeutics, inc. (OHRP)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Jun'10
REVENUES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

0

0

0

0

COST OF SALES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

0

0

0

0

GROSS PROFIT

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

0

0

0

0

OPERATING EXPENSES
General and administrative

2,739

2,554

5,870

888

1,914

422

698

834

591

1,510

723

1,404

1,404

1,746

1,806

1,664

2,966

1,218

1,807

1,554

3,334

812

2,105

785

1,338

57

1,533

138

33

70

36

30

35

32

34

18

23

29

340

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

384

-

319

74

47

517

133

160

64

159

75

63

39

-

Research and development

1,616

1,227

4,152

82

33

4

76

52

1,801

2,387

4,248

2,233

5,993

4,931

4,702

5,637

4,043

2,076

1,299

1,496

3,175

2,805

1,256

1,152

607

1,352

1,325

416

433

578

585

353

351

336

118

120

64

218

14

Research and development expense- license acquired

0

0

-

-

0

1,046

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

285

-1,403

1,315

174

-504

826

-1,031

-2,835

-11

-97

140

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-171

104

-1,305

2,557

486

-20

-3,786

683

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on Impairment of intangible asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on settlement of liabilities

-

-

-

-

-

-

-

-

1,228

-

-

70

-

-

-

-

710

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of Intangibles

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

338

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Salaries and wages

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

227

-

461

126

119

107

117

359

63

64

87

64

63

-

TOTAL OPERATING EXPENSES

4,355

3,782

-

-

1,947

1,473

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,021

-

1,335

668

814

1,247

634

907

497

375

301

215

350

354

LOSS FROM OPERATIONS

-4,355

-3,782

-21,778

-1,136

-1,947

-1,473

-6,371

-1,166

-2,183

-4,182

-5,258

-3,855

-7,689

-6,975

-6,809

-7,598

-6,596

-3,592

-3,740

-3,334

-6,806

-3,923

-3,078

-2,054

-1,968

-2,021

-1,802

-1,335

-668

-814

-1,247

-634

-907

-497

-375

-301

-215

-350

-354

OTHER INCOME (EXPENSE)
Depreciation and amortization

-

-

-

165

-

-

282

279

278

284

286

288

291

298

299

296

296

297

295

283

295

305

-

116

22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on impairment of goodwill

-

-

-

-

-

-

-

-

740

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

0

1

-

-

43

14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

0

0

1

2

0

0

0

0

0

0

0

0

0

2

2

Change in fair value of warrant liabilities

-69

694

-

-

38

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of fixed asset

0

-3

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity in losses on equity method investment

-92

-24

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-5

-30

-41

-26

-10

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expenses

-

-

-

-

-

14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

70

0

0

Gain on settlement of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

21

49

0

0

0

-

Total other expense, net

-23

-723

-

-

-82

-14

-

610

-1

-

-

5

-

0

0

0

0

3

7

0

0

35

-

7

-

-

0

0

90

0

0

0

0

0

0

0

0

1

39

Interest income (expense), net

-

-

-

3

-

-

-

10

-

31

-

-50

-0

-

2

3

5

0

-3

-2

-0

-0

-6

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Other Income

-

-

-

3

-

-

15

621

-1

31

13

-44

-0

0

173

-101

1,311

-2,553

-112

-11

3,405

-674

-11

4

0

-0

-1

-2

375

-1,403

1,314

173

-504

847

-982

-2,836

58

-98

177

LOSS FROM OPERATIONS BEFORE INCOME TAXES

-

-

-

-

-

-

-

-

-

-4,151

-

-

-7,690

-6,975

-6,636

-7,699

-5,284

-6,145

-3,852

-3,345

-3,400

-4,598

-3,089

-2,050

-1,968

-2,021

-1,803

-1,338

-292

-2,218

67

-460

-1,412

350

-1,358

-3,137

-156

-448

-176

INCOME TAXES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

0

-

0

0

0

0

0

0

0

0

LOSS BEFORE DISCONTINUED OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-292

-2,218

-

-460

-1,412

350

-1,358

-3,137

-156

-448

-176

Income from discontinued operations(including gain on disposal of $606,000)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

GAIN ON DISCONTINUED OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

NET LOSS

-4,378

-4,505

-22,306

-1,132

-2,029

-1,488

-6,355

-545

-2,184

-4,151

-5,244

-3,900

-7,690

-6,975

-6,636

-7,699

-5,284

-6,145

-3,852

-3,345

-3,400

-4,598

-3,089

-2,050

-1,968

-2,021

-1,803

-1,338

-292

-2,218

67

-460

-1,412

350

-1,358

-3,137

-156

-448

-176

Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.02

-

-

-0.03

-0.03

0.01

-

-0.08

0.00

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

0.00

0.00

0.00

-

0.00

0.00

-

-

BASIC AND DILUTED LOSS PER SHARE (in dollars per share)

-0.26

-0.26

-2.28

-0.40

-0.33

-0.25

2.21

-0.19

-0.77

-1.48

0.00

-0.07

-0.21

-0.21

-0.21

-0.24

-0.17

-0.20

-0.13

-0.11

-0.12

-0.18

-0.12

-0.09

-0.10

-0.10

-0.07

-0.07

-0.02

-0.14

-0.05

-0.03

-0.03

0.01

-

-0.08

0.00

-

-

WEIGHTED AVERAGE SHARES OUTSTANDING:
BASIC AND DILUTED

17,075

17,071

18,319

2,829

6,074

5,863

217,142

2,823

2,823

2,810

55,521

53,986

36,738

32,836

32,078

31,501

31,344

30,472

30,321

30,323

27,713

25,259

24,969

23,486

20,237

19,872

24,330

18,707

15,935

15,857

-

14,011

41,620

-

-

39,702

39,702

-

35,379

Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

0.00

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

[EarningsPerShareBasic]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

0.00

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,041

-

-

-

35,593

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53,142

-

-

-

0

-